XML 16 R6.htm IDEA: XBRL DOCUMENT v3.20.2
Interim Consolidated Statements of Stockholders' Equity - USD ($)
Total
Cumulative adjustment for the adoption of amendment
Preferred Stock
Common Stock
Additional Paid-in Capital
Retained Earnings
Retained Earnings
Cumulative adjustment for the adoption of amendment
Accumulated Other Comprehensive Income (Loss)
Total SVBFG Stockholders’ Equity
Total SVBFG Stockholders’ Equity
Cumulative adjustment for the adoption of amendment
Noncontrolling Interests
Balance (in shares) at Dec. 31, 2018       52,586,498              
Balance, beginning of period, net of tax at Dec. 31, 2018 $ 5,264,843,000   $ 0 $ 53,000 $ 1,378,438,000 $ 3,791,838,000   $ (54,120,000) $ 5,116,209,000   $ 148,634,000
Balance, beginning of period, net of tax (Accounting Standards Update 2017-08) at Dec. 31, 2018 [1]   $ (583,000)         $ (583,000)     $ (583,000)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Acquisition of SVB Leerink 5,256,000                   5,256,000
Common stock issued under employee benefit plans, net of restricted stock cancellations (in shares)       487,101              
Common stock issued under employee benefit plans, net of restricted stock cancellations 9,236,000     $ 0 9,236,000       9,236,000    
Common stock issued under ESOP (in shares)       14,442              
Common stock issued under ESOP 3,506,000       3,506,000       3,506,000    
Net income 909,901,000         874,000,000     874,000,000   35,901,000
Capital calls and distributions, net (32,002,000)                   (32,002,000)
Net change in unrealized gains and losses on AFS securities, net of tax 173,235,000             173,235,000 173,235,000    
Amortization of unrealized holding gains on securities transferred from AFS to HTM, net of tax (1,275,000)             (1,275,000) (1,275,000)    
Foreign currency translation adjustments, net of tax (4,550,000)             (4,550,000) (4,550,000)    
Net change in unrealized gains and losses on cash flow hedges, net of tax 22,863,000             22,863,000 22,863,000    
Share-based compensation, net 50,550,000       50,550,000       50,550,000    
Common stock repurchases (in shares)       (1,532,210)              
Common stock repurchases (352,511,000)     $ (1,000)   (352,510,000)     (352,511,000)    
Balance (in shares) at Sep. 30, 2019       51,555,831              
Balance, end of period, net of tax at Sep. 30, 2019 6,048,469,000   0 $ 52,000 1,441,730,000 4,312,745,000   136,153,000 5,890,680,000   157,789,000
Balance (in shares) at Jun. 30, 2019       51,561,719              
Balance, beginning of period, net of tax at Jun. 30, 2019 5,706,175,000   0 $ 52,000 1,421,565,000 4,051,194,000   81,232,000 5,554,043,000   152,132,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Common stock issued under employee benefit plans, net of restricted stock cancellations (in shares)       19,674              
Common stock issued under employee benefit plans, net of restricted stock cancellations 1,383,000       1,383,000       1,383,000    
Net income 281,718,000         267,281,000     267,281,000   14,437,000
Capital calls and distributions, net (8,780,000)                   (8,780,000)
Net change in unrealized gains and losses on AFS securities, net of tax 50,638,000             50,638,000 50,638,000    
Amortization of unrealized holding gains on securities transferred from AFS to HTM, net of tax (270,000)             (270,000) (270,000)    
Foreign currency translation adjustments, net of tax (4,482,000)             (4,482,000) (4,482,000)    
Net change in unrealized gains and losses on cash flow hedges, net of tax 9,035,000             9,035,000 9,035,000    
Share-based compensation, net 18,782,000       18,782,000       18,782,000    
Common stock repurchases (in shares)       (25,562)              
Common stock repurchases (5,730,000)         (5,730,000)     (5,730,000)    
Balance (in shares) at Sep. 30, 2019       51,555,831              
Balance, end of period, net of tax at Sep. 30, 2019 6,048,469,000   0 $ 52,000 1,441,730,000 4,312,745,000   136,153,000 5,890,680,000   157,789,000
Balance (in shares) at Dec. 31, 2019       51,655,607              
Balance, beginning of period, net of tax at Dec. 31, 2019 6,621,080,000   340,138,000 $ 52,000 1,470,071,000 4,575,601,000   84,445,000 6,470,307,000   150,773,000
Balance, beginning of period, net of tax (Accounting Standards Update 2016-13) at Dec. 31, 2019 [1]   $ (35,049,000)         $ (35,049,000)     $ (35,049,000)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Common stock issued under employee benefit plans, net of restricted stock cancellations (in shares)       364,494              
Common stock issued under employee benefit plans, net of restricted stock cancellations 15,691,000     $ 0 15,691,000       15,691,000    
Common stock issued under ESOP (in shares)       12,094              
Common stock issued under ESOP 2,447,000       2,447,000       2,447,000    
Net income 855,493,000         815,458,000     815,458,000   40,035,000
Capital calls and distributions, net (16,363,000)                   (16,363,000)
Net change in unrealized gains and losses on AFS securities, net of tax 392,725,000             392,725,000 392,725,000    
Amortization of unrealized holding gains on securities transferred from AFS to HTM, net of tax (765,000)             (765,000) (765,000)    
Foreign currency translation adjustments, net of tax 871,000             871,000 871,000    
Net change in unrealized gains and losses on cash flow hedges, net of tax 143,118,000             143,118,000 143,118,000    
Share-based compensation, net 60,733,000       60,733,000       60,733,000    
Common stock repurchases (in shares)       (244,223)              
Common stock repurchases (60,020,000)     $ 0   (60,020,000)     (60,020,000)    
Dividends on preferred stock (12,557,000)         (12,557,000)     (12,557,000)    
Other (24,000)       (24,000)       (24,000)    
Balance (in shares) at Sep. 30, 2020       51,787,972              
Balance, end of period, net of tax at Sep. 30, 2020 7,967,380,000   340,138,000 $ 52,000 1,548,918,000 5,283,433,000   620,394,000 7,792,935,000   174,445,000
Balance (in shares) at Jun. 30, 2020       51,740,714              
Balance, beginning of period, net of tax at Jun. 30, 2020 7,468,313,000   340,138,000 $ 52,000 1,522,728,000 4,841,720,000   614,735,000 7,319,373,000   148,940,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Common stock issued under employee benefit plans, net of restricted stock cancellations (in shares)       47,258              
Common stock issued under employee benefit plans, net of restricted stock cancellations 4,797,000       4,797,000       4,797,000    
Net income 474,055,000         446,307,000     446,307,000   27,748,000
Capital calls and distributions, net (2,243,000)                   (2,243,000)
Net change in unrealized gains and losses on AFS securities, net of tax 10,018,000             10,018,000 10,018,000    
Amortization of unrealized holding gains on securities transferred from AFS to HTM, net of tax (266,000)             (266,000) (266,000)    
Foreign currency translation adjustments, net of tax 7,475,000             7,475,000 7,475,000    
Net change in unrealized gains and losses on cash flow hedges, net of tax (11,568,000)             (11,568,000) (11,568,000)    
Share-based compensation, net 21,408,000       21,408,000       21,408,000    
Dividends on preferred stock (4,594,000)         (4,594,000)     (4,594,000)    
Other (15,000)       (15,000)       (15,000)    
Balance (in shares) at Sep. 30, 2020       51,787,972              
Balance, end of period, net of tax at Sep. 30, 2020 $ 7,967,380,000   $ 340,138,000 $ 52,000 $ 1,548,918,000 $ 5,283,433,000   $ 620,394,000 $ 7,792,935,000   $ 174,445,000
[1] See "Adoption of New Accounting Standards" in Note 1 — “Basis of Presentation” of the “Notes to Interim Consolidated Financial Statements (unaudited)” under Part I, Item 1 of this report for additional details.